Technical Analysis for AGL - Angle Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Flat | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| Crossed Above 200 DMA | Bullish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Bearish Engulfing | Bearish | 3.57% | |
| Fell Below 200 DMA | Bearish | 3.57% | |
| Fell Below 50 DMA | Bearish | 3.57% |
| Alert | Time |
|---|---|
| Possible Inside Day | about 15 hours ago |
| Upper Bollinger Band Resistance | about 19 hours ago |
| 3x Volume Pace | about 19 hours ago |
| 2x Volume Pace | about 19 hours ago |
| 1.5x Volume Pace | about 19 hours ago |
Get a Trading Sidekick!
Angle Plc Description
ANGLE plc is a holding company. The Company's principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The resulting liquid biopsy (blood test) enables the detection and investigation of mutations in the patient's cancer for personalized cancer care. The harvested CTCs have a range of applications, including diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Medicine Cancer Medical Specialties Monitoring Nature Clinical Medicine Oncology Fluid Offers Products Blood Drug Development Tumor Personalized Cancer Anatomical Pathology Biopsy Circulating Tumor Cell Medical Diagnostic
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 37.4 |
| 52 Week Low | 9.0667 |
| Average Volume | 1,290,156 |
| 200-Day Moving Average | 14.11 |
| 50-Day Moving Average | 14.50 |
| 20-Day Moving Average | 13.07 |
| 10-Day Moving Average | 13.00 |
| Average True Range | 1.55 |
| RSI (14) | 54.75 |
| ADX | 23.12 |
| +DI | 36.55 |
| -DI | 15.49 |
| Chandelier Exit (Long, 3 ATRs) | 12.98 |
| Chandelier Exit (Short, 3 ATRs) | 15.90 |
| Upper Bollinger Bands | 15.32 |
| Lower Bollinger Band | 10.82 |
| Percent B (%b) | 0.82 |
| BandWidth | 34.42 |
| MACD Line | -0.12 |
| MACD Signal Line | -0.43 |
| MACD Histogram | 0.3114 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 16.76 | ||||
| Resistance 3 (R3) | 16.80 | 16.09 | 16.39 | ||
| Resistance 2 (R2) | 16.09 | 15.51 | 16.07 | 16.26 | |
| Resistance 1 (R1) | 15.29 | 15.16 | 15.69 | 15.25 | 16.13 |
| Pivot Point | 14.58 | 14.58 | 14.78 | 14.56 | 14.58 |
| Support 1 (S1) | 13.79 | 14.00 | 14.18 | 13.75 | 12.87 |
| Support 2 (S2) | 13.07 | 13.65 | 13.05 | 12.74 | |
| Support 3 (S3) | 12.28 | 13.07 | 12.61 | ||
| Support 4 (S4) | 12.24 |
